-
UBS Reaffirms Buy Rating on Abbott Laboratories (ABT) Amid Exact Sciences Acquisition
29 Nov 2025 18:54 GMT
… cancer care with this acquisition. Abbott Laboratories (NYSE:ABT) will also add … Diagnostics, UBS is adamant that Abbott Laboratories (NYSE:ABT) will consistently outperform … a wide range of branded generic medications, medical devices, diagnostics, and …
-
Is Abbott Laboratories Stock Underperforming the S&P 500?
26 Nov 2025 11:58 GMT
… , medical devices, nutritional, and branded generic medicines.
Companies worth $200 billion … "mega-cap stocks." Abbott Laboratories fits right into that category … bearish trend.
www.barchart.com
Abbott Laboratories’ stock prices dropped 2.9% …
-
Generic Drugs Market Size to Worth USD 898 Billion by 2035, at a CAGR of 5.75% | Research by Vantage Market Research
25 Nov 2025 11:48 GMT
… from traditional small-molecule generics to complex generics, biosimilars, 505(b)(2 … Key Players for Generic Drugs Market
Mylan N.V.
Abbott Laboratories
ALLERGAN
Teva … and regulated markets.
Branded Generic Drugs: Branded generics continue to grow steadily …
-
Abbott Laboratories (ABT) Rated Buy as Benchmark Highlights Diagnostics Growth and Global Resilience
21 Oct 2025 10:46 GMT
Abbott Laboratories (NYSE:ABT) ranks among … in. Benchmark began coverage of Abbott Laboratories (NYSE:ABT) on October … for any upcoming tariff talks. Abbott Laboratories (NYSE:ABT) is a … a wide range of branded generic medications, medical devices, diagnostics, …
-
Forecasting The Future: 12 Analyst Projections For Abbott Laboratories
07 Oct 2025 19:43 GMT
… date on Abbott Laboratories analyst ratings.
Unveiling the Story Behind Abbott Laboratories
Abbott … and testing kits, and branded generic drugs. Products include pacemakers, … sales outside the United States.
Abbott Laboratories: A Financial Overview
Market …
-
Glenmark to launch generic drug to treat metabolic acidosis in US
04 Nov 2025 15:45 GMT
… in the United States. This generic medication treats high acid levels … drug is therapeutically equivalent to Abbott Laboratories' product. This move follows …
-
Medical Foods For Inborn Errors Of Metabolism Market Competition Analysis 2025: How Players Are Shaping Growth
10 Dec 2025 00:00 GMT
… products, and intravenously administered generic drugs
How Concentrated Is the … Different Regions?
• North America: Abbott Laboratories, Nutricia Ltd, Ajinomoto Cambrooke, … Fresenius Kabi Australia Pty Ltd, Abbott Laboratories Indonesia, and Ajinomoto Co, …
-
Antidepressants Market to Reach USD $19.92 Billion by 2029 at 2.7% CAGR
09 Dec 2025 15:45 GMT
… , market rivalry, expansion in the generic market, an emphasis on side … Squibb Company
• Fresenius Kabi AG
• Abbott Laboratories
What Are The Upcoming Trends …
-
Abbott Laboratories (NYSE:ABT) Q2 2025 Earnings Call Transcript
19 Jul 2025 12:45 GMT
… areas of growth for branded generic medicines. The growth in these … a broad portfolio of branded generic medicines tailored to local conditions … a wonderful day.
Follow Abbott Laboratories (NYSE:ABT) Follow Abbott Laboratories (NYSE:ABT) We …
-
Abbott Laboratories CEO calls post-earnings stock decline 'a little bit of an overreaction'
18 Jul 2025 01:32 GMT
… devices, diagnostics, nutritional products and generic pharmaceuticals. The company is currently … also said Abbott's generic pharmaceutical business is doing well … Investing Club holds shares of Abbott Laboratories.
Questions for Cramer?
Call Cramer …